Manufacturing and Production

Showing 15 posts of 5866 posts found.

Pfizer says Brexit will cost the company $100 million

September 4, 2018 Manufacturing and Production EU, Pfizer, UK, brexit, pharma

The US multinational Pfizer has said that Brexit will cost the company $100 million in costs associated with the transference …
371628984_a662993bf6_z

Antibiotic combinations could help in fight against antimicrobial resistance

September 4, 2018 Manufacturing and Production AMR, Antibiotics, antibiotic resistance, e coli, ucla

Antimicrobial resistance (AMR) could be tackled by giving people a combination of antibiotic drugs that are no longer effective on …

Faubel-Booklet Labels

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Faubel-Booklet Labels with temperature indicators from ELPRO identify and monitor pharmaceutical products Melsungen, 3rd of September 2018Pharmaceutical products without proper …
shutterstock_192094955_web

Widening the focus on innovations in cancer treatment

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma

Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …

DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
eisa0008_web

Eisai’s weight loss drug lorcaserin found safe in major study

August 28, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss

Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 …

Ionis/Akcea’s ultra-rare disease drug rejected by FDA

August 28, 2018 Manufacturing and Production, Sales and Marketing Akcea, FDA, Ionis, familial chylomicronemia syndrome, pharma, rare disease

The FDA has opted to refuse approval to Akcea and Ionis’ Waylivra (volanesorsen) for the treatment of the ultra-rare hereditary …
26022266362_1bf5a2747e_z

Researchers develop anti-nicotine addiction drugs

August 28, 2018 Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university

Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …
european_commission_web

Novartis’ Kymriah & Gilead’s Yescarta become first EU-approved CAR T therapies

August 28, 2018 Manufacturing and Production, Sales and Marketing CAR T, CAR-T, Cancer, EU, Gilead, Kymriah, Novartis, UK, Yescarta, blood cancer, pharma

Almost one full year since the treatment was given a “historic” approval in the US, Novartis’ CAR T therapy Kymriah …
social_media_phone_iphone_twitter_hand-38920

Russian trolls spread vaccine misinformation on Twitter

August 28, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines

Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …

GE Healthcare set to open biotech hub in Uppsala, Sweden

August 23, 2018 Manufacturing and Production, Research and Development GE Healthcare, Sweden, Testa Centre, Uppsala, biotech

The American multinational GE Healthcare is opening a 27,000-sq-ft innovation centre in Uppsala, Sweden in an effort to boost the …
The Gateway to Local Adoption Series

Latest content